Tdap vax safe during pregnancy; UNICEF opens Fiji facility; Novavax appoints new SVP;

> Receiving the Tdap vaccine during pregnancy does not increase the risk of adverse events for the mother or the infant, a JAMA study says. Release

> UNICEF has opened a vaccine storage facility in Fiji that will deliver to 13 countries across the region. More

> Novavax ($NVAX) has appointed Sven Andréasson its SVP of corporate development. Release

> Savsu Technologies has scored World Health Organization approval for its new long-range vaccine carrier. Release

> Researchers are pursuing a powdered nasal vaccine against West Nile. More

> Swedish scientists are looking to test a heart attack vaccine in India. More

> A product design student in India has developed a portable vaccine cooler for the last mile of the cold chain. More

And Finally... Maryland-based biotech Sanaria is hoping to crowdfund the production of a robot that can manufacture its malaria vaccine candidate. More

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.